A CDC panel decided to end the universal birth dose of a hepatitis B vaccine for newborns, with some officials pointing to ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

On the campaign trail last October, President Trump promised to let his health secretary, Robert F. Kennedy Jr., “go wild on ...

By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Key Takeaways The U.S. Food and Drug Administration is reviewing two RSV drugs for infantsNo safety issues have been ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children. But a new ...